Ch. 11: Multi-Step Tumorigenesis Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Cancer risk _______ with age.
Interpretation- ….

A
  • increases
  • It takes time for cancer to form.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Can we estimate how long it takes for cancer to
form?

A

Generally, not really.
* Dependent on random mutational events (hard to predict)
* But we can do so here, with lung cancer risk and a known source of cancer (smoking tobacco)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why do cancers take a long time to form?

A

Hypothesis-
* Cancer formation is a multi-step process
* A sequence of unlikely events must occur for a tumor to form
* As we grow older we accumulate cells at many places in our bodies that have undergone some but not all steps of tumor progression
* Autopsy reports show that ~65% of individuals carry undiagnosed tumors, independent of the cause of death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Histopathology

A

examining tissues under a microscope to study disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What suggests cancers develop in a multi-step process?

A

A spectrum of tissue morphologies exist between
normal and highly malignant
* Suggests, cancers develop in a multi-step process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hyperplasia

A

Individual cells look normal but there is evidence of increased
cell divisions. Usually, the tissue looks thicker.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dysplasia

A
  • Loss of well-ordered single layer of cells
  • Morphology looks subtly different than normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In situ cancer

A
  • More severely abnormal growth
  • Benign- stay in the tissue of origin
  • Usually not diagnosed as a cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metastatic Cancer

A
  • More severely abnormal growth
  • Evidence of malignancy- cells have migrated out of the tissue of origin, into distant sites of the body
  • Diagnosed as cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Progression does not inevitably happen

A
  • Impact on early screening
  • Unnecessarily overtreating patients with pre-metastatic lesions that may not ever develop to cancer.
  • Active area of research- Identify which early lesions are
    a high risk to develop into metastatic cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prediction: Genetic mutations accumulate as progression proceeds
Experiment: Determine if there is an increase in mutations in tissues at each stage of progression
Results: ?
Updates Results: ?

A

Results: Mutations accumulate as cancer progresses
* Colon cancer at the following progression stages:
* Small adenoma, mid-size adenoma, large adenoma, carcinomas

Results:
- Common genes/regions were mutated at specific stages in colorectal cancer progression
* Common genes/regions were mutated at specific stages in colorectal cancer progression

  • Interpretations:
  • LOH Chr. 5q was seen in all stages of cancer progression
  • Activated K-ras was seen in intermediate adenomas and all stages of progression after that
  • Carcinomas have all of these mutations: LOH Chr. 5q, activation of K-ras, LOH Chr 18q, and LOH Chr. 17p

Updated results: Pathways involved in colon carcinoma progression
* Since the original study, researchers have further characterized the molecules and pathways effected by each mutation.
* Generally, carcinoma tumor progression involves the following genetic mutations in the following order of progression (slide 23)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A model of all the pathways mutated in colon carcinoma progression

A
  • In reality, there is more than 1 way colon cancers develop
  • In general, genes in 4 major
    pathways are mutated
  • B-catenin mutations occur
    relatively early in progression
  • TP53 mutations occur relatively late in progression
  • Some mutations are more
    frequent than others
  • Some mutations are more likely to occur together (Ex- B-raf and SMAD4)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Genes that are commonly mutated during cancer
progression contribute to…

A

common phenotypes of cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cancer development through a lens of evolution (slides 27-31)

A
  • Each individual cell in a tissue is in competition with other individual cells
  • If a cell happens to get a mutation that increases its fitness relative to other cells then it will accumulate in
    higher numbers compared to non-mutated cells
  • Idea- a random mutation in 1 cell gives it a proliferative advantage compared to other cells.
  • This cell and it’s descendants will come to dominate the tissue.
  • When this cell and it’s descendants gets to large numbers; a second mutation is mathematically possible.
  • If the second mutation gives an additional fitness advantage, then it and its descendants will come to dominate the tissue
  • When this cell and it’s descendants gets to large numbers; a third mutation is mathematically possible.
  • If the second mutation gives an additional fitness advantage, then it and its descendants will come to dominate the tissue.
  • Clonal expansion: when a single cell contributes to a population of cells.
  • Idea: Cancer progression involves a number of clonal expansions.
  • Each mutation must be
    complementary, act on a separate molecular pathway, and confer an increased fitness relative to the prior mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clonal Expansion

A

when a single cell contributes to a population of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In vivo evidence for clonal expansion

A
  • Sun exposed human skin can contain patches of cells with TP53 mutated.
  • Patches can consist of up to 3000 mutant cells.
  • Fertile ground for further tumor development
  • TP53 mutant cells accumulate in a small patch of cells in the oral epithelium.
  • TP53 mutant cells accumulate in larger domain domains as cancer progression proceeds
17
Q

In vivo evidence for oncogene complementation

A
  • T50 = Time at which half of the mice have mammary
    carcinoma
  • MYC deficient mice T50 = 325
  • RAS deficient mice T50 = 168
  • Mice deficient in both MYC and RAS T50 = 46 days
  • Interpretations:
  • Mutations in molecules from
    different pathways lead to
    increased cancer progression/risk
  • A single mutation is not sufficient to cause cancer
18
Q

Cancer progression and genomic instability

A
  • As cancer progression proceeds the genome becomes increasingly destabilized.
  • As a result, during the latest stages of progression, rates of genetic change outpace the rate that evolution eliminates less-fit cells.
  • Contributes to intra-tumoral
    heterogeneity: populations of cells within a tumor with genetic diversity
19
Q

intra-tumoral heterogeneity

A

populations of cells within a tumor with genetic diversity

20
Q

Evidence of intra-tumoral heterogeneity

A
  • Cells from lung carcinoma
  • Fluctuations in chromosome
    number from cell to cell
  • Highly polyploid giant nuclei are also apparent